NCT06816108 2026-01-12
A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors
Ono Pharmaceutical Co. Ltd
Phase 1 Recruiting
Ono Pharmaceutical Co. Ltd
Allist Pharmaceuticals, Inc.
InventisBio Co., Ltd
Betta Pharmaceuticals Co., Ltd.